Braun Stacey Associates Inc Bristol Myers Squibb CO Transaction History

Braun Stacey Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $16.8 Million - $19.6 Million	-312,770 Closed	0 $0
Q3 2021 Dec 01, 2021	SELL	$59.17 - $69.31 $567,854 - $665,168	-9,597 Reduced 2.98%	312,770 $18.5 Million
Q2 2021 Jul 23, 2021	SELL	$61.91 - $67.42 $203,993 - $222,148	-3,295 Reduced 1.01%	322,367 $21.5 Million
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $309,517 - $348,115	5,216 Added 1.63%	325,662 $20.6 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $420,404 - $476,395	7,281 Added 2.32%	320,446 $19.9 Million

Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $24,694 - $27,365	430 Added 0.14%	313,165 $18.9 Million
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $413,562 - $483,494	7,544 Added 2.47%	312,735 $18.4 Million
Q1 2020 Jun 09, 2020	SELL	$46.4 - $67.43 $304,105 - $441,936	-6,554 Reduced 2.1%	305,191 $17 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $15.3 Million - $20 Million	311,745 New	311,745 $20 Million

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Braun Stacey Associates Inc with notifications on news.